Unknown

Dataset Information

0

CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.


ABSTRACT: T cell adoptive transfer strategies that have produced clinical remissions against specific tumors have so far produced disappointing results against ovarian cancer. Recent evidence suggests that adoptively transferred CD4(+) T cells can trigger endogenous immune responses in particular patients with ovarian cancer through unknown mechanisms. However, conflicting reports suggest that ovarian cancer-infiltrating CD4(+) T cells are associated with negative outcomes. In this study, we elucidate the phenotypic attributes that enable polyclonal CD4(+) T cells briefly primed against tumor Ags to induce therapeutically relevant endogenous antitumor immune responses. Our results unveil a therapeutic mechanism whereby tumor-primed CD4(+) T cells transferred into ovarian cancer-bearing mice secrete high levels of CCL5, which recruits endogenous CCR5(+) dendritic cells to tumor locations and activate them through CD40-CD40L interactions. These newly matured dendritic cells are then able to prime tumor-specific endogenous CD8(+) T cells, which mediate long-term protection. Correspondingly, administration of tumor-primed CD4(+) T cells significantly delayed progression of MHC class II(-) ovarian cancers, similarly to CD8(+) T cells only, and directly activated wild-type but not CD40-deficient dendritic cells recruited to the tumor microenvironment. Our results unveil a CCL5- and CD40L-dependent mechanism of transferring immunity from exogenously activated CD4(+) T cells to tumor-exposed host cells, resulting in sustained antitumor effects. Our data provide a mechanistic rationale for incorporating tumor-reactive CD4(+) T cells in adoptive cell transfer immunotherapies against ovarian cancer and underscore the importance of optimizing immunotherapeutic strategies for the specific microenvironment of individual tumors.

SUBMITTER: Nesbeth YC 

PROVIDER: S-EPMC2874073 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

CD4+ T cells elicit host immune responses to MHC class II-negative ovarian cancer through CCL5 secretion and CD40-mediated licensing of dendritic cells.

Nesbeth Yolanda C YC   Martinez Diana G DG   Toraya Seiko S   Scarlett Uciane K UK   Cubillos-Ruiz Juan R JR   Rutkowski Melanie R MR   Conejo-Garcia Jose R JR  

Journal of immunology (Baltimore, Md. : 1950) 20100416 10


T cell adoptive transfer strategies that have produced clinical remissions against specific tumors have so far produced disappointing results against ovarian cancer. Recent evidence suggests that adoptively transferred CD4(+) T cells can trigger endogenous immune responses in particular patients with ovarian cancer through unknown mechanisms. However, conflicting reports suggest that ovarian cancer-infiltrating CD4(+) T cells are associated with negative outcomes. In this study, we elucidate the  ...[more]

Similar Datasets

| S-EPMC8384835 | biostudies-literature
| S-EPMC3511074 | biostudies-literature
| S-EPMC7065958 | biostudies-literature
| S-EPMC2862662 | biostudies-literature
| S-EPMC7259512 | biostudies-literature
| S-EPMC3215013 | biostudies-literature
| S-EPMC1855382 | biostudies-literature
| S-EPMC4033297 | biostudies-literature
| S-EPMC137536 | biostudies-literature
| S-EPMC3831452 | biostudies-literature